Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Aurobindo Pharma Ltd

Aurobindo Pharma Ltd share price and stock overview

Aurobindo Pharma Ltd (NSE: AUROPHARMA, BSE: 524804) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE406A01037 and a face value of Rs 1. As of 07 August 2026, it trades at Rs (1,658.00) with a market capitalisation of Rs 92318.42 crore. Figures are live and subject to change.

Aurobindo Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
1,658.00 69.10 (4.35%) upARrowC
As on: 07-Aug-2026 , 06:29 PM
Market Cap(₹Cr) 92318.42
Book Value(₹Cr) 391.1437121
BSE Code : 524804 NSE Symbol : AUROPHARMA EPS(TTM) : 41.81 ISIN Demat : INE406A01037 P/E(TTM) : 38.02 Face Value(₹) : 1 Div & Yield % : 0.25

Today Market

Stock Performance

Today Market

Today's High

78,757.40

Todday's Low

78,377.07

Open at

78,516.08

Previous Close

78,954.76

Volumes

Avg Price

-455.59

Historical Performance

News

05 Aug 26
Aurobindo Pharma’s revenue rose 16.3% to INR 9,150 crore, boosted by US and Europe growth
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804) announced its consolidated financial results for the quarter ended June 30, 2026, reporting revenue from operations of INR 9,150 crore, a 16.
05 Aug 26
Aurobindo Pharma to merge subsidiaries, streamlining operations and creating synergy benefits
Aurobindo Pharma Ltd. announced that its board of directors has approved a proposal to merge Eugia Steriles Private Limited and Eugia SEZ Private Limited, both wholly owned step-down subsidiaries, with Eugia Pharma Specialities Limited, a wholly owned subsidiary, through a Scheme of Amalgamation to be filed with the National Company Law Tribunal in Hyderabad.
05 Aug 26
Aurobindo Pharma Ltd consolidated sales up 4.05% on year in Q2FY2026, net profit rose by 12.07%
Aurobindo Pharma Ltd share price gained 1.87% to Rs 1613.4 after the company's net profit registered a growth of 12.
03 Aug 26
Aurobindo Pharma receives assurance on its BRSR, confirming adherence to SEBI guidelines
Aurobindo Pharma Limited received a “reasonable assurance” opinion on its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, according to a report released by Sharp & Tannan Associates, Chartered Accountants.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
06-08-26 1625.00 1634.40 1584.20 1588.90 1299019 41141 2078111218.30 24636.00
05-08-26 1587.30 1625.00 1567.00 1613.40 1385223 49197 2226868641.30 24624.65
04-08-26 1555.00 1585.90 1536.80 1585.90 2243122 55048 3501145181.00 24614.90
03-08-26 1586.90 1591.80 1541.60 1554.70 1496353 96457 2341846690.80 24774.30
31-07-26 1582.90 1588.50 1566.10 1580.20 440498 35300 695424405.00 24383.60
30-07-26 1590.00 1607.50 1566.20 1576.30 733318 43782 1164317501.10 24317.15
29-07-26 1556.70 1598.70 1554.40 1590.70 1031789 39184 1636105828.40 24250.20
28-07-26 1550.50 1563.80 1539.90 1549.20 499946 25445 773929574.20 23985.35
27-07-26 1533.50 1568.90 1531.90 1549.40 850225 32164 1321900775.00 23995.95
24-07-26 1512.00 1541.00 1512.00 1532.00 446834 24807 684179901.30 23767.45
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

92318.42

PE Ratio

38.02

PB Ratio

4.06

Dividend Yield

0.25

ROE

11.17

ROCE

12.91

Book Value (₹)

391.1437121

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 17690341 3.07 17690341 1
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 17690341 3.07 17690341 1
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 210859525 36.65 210859525 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 69972860 12.16 69972860 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 280832385 48.81 280832385 13
Total ShareHolding for Promoter & Group 298522726 51.88 298522726 14
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 210 0.00 210 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 94230349 16.38 94230349 674
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 28711115 4.99 28711115 24
Mutual Funds / UTI 96131215 16.71 96131215 42
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 19575841 3.40 19575841 40
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 238648730 41.48 238648730 781
plus  Non Institution
Bodies Corporate 2847086 0.49 2845976 1820
Clearing Members 422236 0.07 422236 6
Directors & their Relatives 4010 0.00 4010 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2161183 0.38 2161183 8173
Foreign Non Institution Other 410 0.00 410 1
Hindu Undivided Families 827397 0.14 827397 3730
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1883878 0.33 1883878 5
Individuals holding nominal share capital up to Rs. 1 lakh 28963904 5.03 28390504 224519
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 155745 0.03 155745 17
Others 939810 0.16 939810 4
Sub Total 38206439 6.64 37631929 238278
Total Public Shareholding 276855169 48.12 276280659 239059
Total of Promoter & Public ShareHolding 575377895 100.00 574803385 239073
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 575377895 100.00 574803385 239073

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales33,653.0831,723.7329,001.8724,855.3823,455.49
OPM (%)15.3815.9715.7610.5114.92
OP5,177.185,066.294,571.852,612.503,500.71
Other Income492.09621.85557.38290.59320.35
PBIDT7,274.017,172.956,191.363,997.564,547.90
INTEREST383.97457.24289.71140.4848.64
PBDT6,890.046,715.715,901.653,857.084,499.26
PBT5,046.525,066.294,188.132,612.503,244.77
EO-65.330.00-191.860.00-127.97
PBT after EO5,111.855,066.294,379.992,612.503,372.74
TAXES1,608.881,582.721,211.02684.85725.63
PAT3,504.753,485.883,172.971,927.502,648.15
EPS60.3459.8154.1632.9045.20
Raw Material30.6233.8437.1638.8331.43
Power and Fuel3.323.192.853.392.67
Employee Cost15.4214.1113.5314.1714.71
Other Manufacturing Expenses1.531.381.391.581.79
Selling and Administration Expenses14.2114.4813.7014.9114.21
Miscellaneous Expenses2.252.312.383.001.96
Revenue (Growth %) 6.089.3916.685.97-5.32
PBIDT (Growth %)1.4115.8554.88-12.10-46.33
PAT (Growth %) 0.549.8664.62-27.21-50.36
PBIDT (Margin %)21.6122.6121.3516.0819.39
PAT (Margin %) 10.4110.9910.947.7511.29

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 58.0858.0858.5958.5958.5958.59
Reserves Total 22659.6120476.0319664.2317975.4417058.7515866.02
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds22717.6920534.1119722.8218034.0317117.3415924.61
Secured Loans 1905.501842.411431.991922.78288.75841.50
Unsecured Loans 2379.742804.191428.752280.381606.143186.02
Total Debt4285.244646.602860.744203.161894.894027.52
Other Liabilities73.1753.3046.0087.315.030.00
Total Liabilities27076.1025234.0122629.5622324.5019017.2619952.13
APPLICATION OF FUNDS :
Gross Block 4633.154230.614043.496214.715724.906820.35
Less : Accumulated Depreciation 2089.421893.811624.362527.212139.072348.28
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 2543.732336.802419.133687.503585.834472.07
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress228.5587.53132.68239.09225.15734.89
Producing Properties0.000.000.000.000.000.00
Investments 17562.3515209.5713393.448105.376584.365009.93
Current Assets, Loans & Advances
Inventories 2360.572359.282367.604125.263356.184841.38
Sundry Debtors 4209.684195.053776.594560.263973.245928.01
Cash and Bank Balance162.50298.3694.34373.4150.78386.18
Loans and Advances 562.93836.701000.59906.052454.901093.25
Total Current Assets7295.687689.397239.129964.989835.1012248.82
Less : Current Liabilities and Provisions
Current Liabilities 2021.212092.612285.862396.312243.302553.47
Provisions 78.3185.01119.65122.09103.36250.01
Total Current Liabilities & Provisions2099.522177.622405.512518.402346.662803.48
Net Current Assets5196.165511.774833.617446.587488.449445.34
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets41.0151.8747.4555.2443.8268.61
Deferred Tax Liability144.77153.30166.36271.15280.85501.99
Net Deferred Tax-103.76-101.43-118.91-215.91-237.03-433.38
Other Assets1649.072189.771969.613061.871370.51723.28
Total Assets27076.1025234.0122629.5622324.5019017.2619952.13
Contingent Liabilities460.34220.81206.15534.26152.93887.66

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -2,447.541,719.48-1,837.03616.31-1,072.35
Investing Activities -1,614.54-3,229.65-151.58-2,050.16-1,995.50
Net Cash Flow -335.37306.00-273.81211.94-134.83
Operating Activities 3,726.711,816.171,714.801,645.792,933.02

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
KNR
Kambam Nityananda Reddy
Vice Chairman & Managing Director
Executive
MRK
M R Kumar
Chairman & Independent Director
Executive
Functional Directors
MMM
M Madan Mohan Reddy
Whole-time Director
WTD
PVR
P V Ramprasad Reddy
Non Executive Director
Exec.
PSC
P Sarath Chandra Reddy
Non Executive Director
Exec.
SM
Satakarni Makkapati
Non Executive Director
Exec.
PKS
Punita Kumar Sinha
Additional Director
Dir.
Independent Directors
GPV
Girish Paman Vanvari
Independent Director
Ind.
SM
Santanu Mukherjee
Independent Director
Ind.
Other Officials
BAR
B Adi Reddy
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Aurobindo Pharma Ltd? −

Aurobindo Pharma Ltd trades on NSE under AUROPHARMA and on BSE under code 524804. The ISIN is INE406A01037 and the face value is Rs 1.

What is the share price of Aurobindo Pharma Ltd today? +

As of 07 August 2026, Aurobindo Pharma Ltd trades at Rs 1,658.00, a change of 69.10 (4.35%) on the day. Prices are live and subject to change.

What is the market capitalisation of Aurobindo Pharma Ltd? +

As of 07 August 2026, Aurobindo Pharma Ltd has a market cap of about Rs 92318.42 crore. This figure is live and moves with the share price.

Is Aurobindo Pharma Ltd profitable? +

In March 2026, Aurobindo Pharma Ltd reported a profit after tax of Rs 3,504.75 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Aurobindo Pharma Ltd? +

: As of 07 August 2026, the PE (TTM) for Aurobindo Pharma Ltd is 38.02 and the price-to-book ratio is 4.06. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Aurobindo Pharma Ltd pay a dividend? +

As of 07 August 2026, the dividend yield for Aurobindo Pharma Ltd is 0.25%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Aurobindo Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 51.88% of Aurobindo Pharma Ltd. Public shareholding is 48.12%, including mutual funds at 16.71% and foreign institutional investors at 16.38%.

What were the latest annual financials of Aurobindo Pharma Ltd? +

In March 2026, Aurobindo Pharma Ltd reported net sales of Rs 33,653.08 crore, revenue growth of 6.08%, and earnings per share of Rs 60.34.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web